Hypertension Research Trial (56 Weeks)

Adults (men and women) with a diagnosis of primary hypertension for at least 6 months, may qualify to participate. Individuals must currently be treated with 2 antihypertensive classes of drug, or currently treated with at least 3 antihypertensive classes of drug including a diuretic, at the maximum tolerated doses of those medications (with no change in the antihypertensive regimen for at least 6 weeks). Systolic BP between 140 mmHg and 179 mmHg (inclusive) at screening, while on current chronic antihypertensive treatments, is also required.

Participants will receive investigational oral medication (active study drug) or placebo. Investigational medication and study-related assessments will be provided at no cost. Reimbursement for study-related expenses may be provided.

Study participation will last about 56 weeks and involve about 12 visits to the study centre, plus 2 phone visits.

Call the study centre near you, or register now.

Learn more about
Hypertension
Register Now!

Participating Locations

AR

  • Sorry no locations are available in this country.

AU

  • Sorry no locations are available in this country.

CL

  • Sorry no locations are available in this country.

MX

  • Sorry no locations are available in this country.

US

  • Sorry no locations are available in this country.

Register for
Active Studies!

Register

All information about you will be kept confidential.

If there are no active studies for your condition, we will keep your information and contact you when a new study starts in your area.

By registering you are consenting to the terms and conditions of our privacy policy.

Find the clinic near you:

Why Take Part In a Clinical Study?

Regulatory agencies like Health Canada, Australia's Therapeutic Goods Administration and the FDA require that Clinical Research Trials be conducted in order to develop new treatments, preventions and devices for diseases or conditions. Clinical Research Trials are also referred to as Clinical Studies or Clinical Trials. read more